IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Medgenics, Inc.
Symbol: MDGN
Price: Last Trade $6.25
Description: Re-offer Range: $5.50-$5.75
Trade Date: 6/21
Shares: 3.6 million
Underwriter(s) Jefferies
Co-Managers: N/A
Rating = Subscription Needed
Company: Paratek Pharmaceuticals
Symbol: PRTK
Price: Last Trade $16.54
Description: Re-offer Range:
Trade Date: 6/22
Shares: 3.75 million
Underwriter(s) Leerink Partners, Guggenheim Securities
Co-Managers: N/A
Rating = Subscription Needed
Company: Scynexis
Symbol: SCYX
Price: Last Trade $2.65
Description: No Re-Offer Available
Trade Date: 6/21
Shares: TBD
Underwriter(s) Guggenheim Securities
Co-Managers: N/A
Rating = Subscription Needed
Company: Communications Sales & Leasing, Inc.
Symbol: CSAL
Price: Last Trade $28.16
Description: Re-offer Range: $24.00-$26.00
Trade Date: 6/21
Shares: 14.7 million
Underwriter(s) Citigroup, BofA Merrill Lynch, Barclays, Credit Suisse Securities, Goldman Sachs & Co., J.P. Morgan, Wells Fargo Securities
Co-Managers: N/A
Rating = Subscription Needed